Heimdall Insights

Global Radiation Syndrome Treatment Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Radiation Syndrome Treatment Market was valued at $5.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.5% CAGR, to an estimated market size of $6.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global radiation syndrome treatment market encompasses pharmaceutical interventions, biologics, and medical countermeasures designed to treat or mitigate the effects of Acute Radiation Syndrome (ARS), chronic radiation injuries, and radiation toxicity. This scope includes radioprotectors, radiomitigators, and radiorecovery agents used in response to nuclear incidents, industrial accidents, or as supportive care to manage side effects from oncological radiotherapy, while excluding the radiation therapy equipment itself.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Radiation Syndrome Treatment Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia Pacific
  • Rest of World

Segments

  • Hematopoietic Syndrome (HSC) Treatments
  • Gastrointestinal (GI) Syndrome Treatments
  • CNS & Cardiovascular Syndrome Treatments
  • Chronic & Supportive Care Agents